Radioembolization as a Salvage Therapy for Heavily Pretreated Patients with Colorectal Cancer Liver Metastases: Factors That Affect Outcomes

Clinical Colorectal Cancer

Volumn 14, Issue 4, 2015, Pages 296-305

  Sofocleous, Constantinos T ^a   Violari, Elena G ^a   Sotirchos, Vlasios S ^a   Shady, Waleed ^a   Gonen, Mithat ^a   Pandit Taskar, Neeta ^a   Petre, Elena N ^a   Brody, Lynn A ^a   Alago, William ^a   Do, Richard K ^a   D'Angelica, Michael I ^a   Osborne, Joseph R ^a   Segal, Neil H ^a   Carrasquillo, Jorge A ^a   Kemeny, Nancy E ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Arterially directed therapies; Hepatic malignancy; Selective internal radiation therapy; SIRT; Yttrium 90

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; RESIN MICROSPHERE Y 90; TRACER; UNCLASSIFIED DRUG; YTTRIUM;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGED; APPETITE DISORDER; ARTICLE; ARTIFICIAL EMBOLISM; CANCER MORTALITY; CANCER STAGING; CLINICAL EVALUATION; COLORECTAL CANCER; CONSTIPATION; DATA BASE; DIARRHEA; DISEASE COURSE; DYSPNEA; EPIGASTRIC PAIN; FATIGUE; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPERBILIRUBINEMIA; LIVER FAILURE; LIVER METASTASIS; LIVER TOXICITY; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NAUSEA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RADIATION PNEUMONIA; RADIOEMBOLIZATION; RETROSPECTIVE STUDY; SALVAGE THERAPY; THERAPY EFFECT; VOMITING; ADVERSE EFFECTS; ARTIFICIAL EMBOLIZATION; BLOOD; COLORECTAL NEOPLASMS; DISEASE FREE SURVIVAL; LIVER NEOPLASMS; PATHOLOGY; PROCEDURES; SECONDARY; SURVIVAL RATE; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT; YTTRIUM RADIOISOTOPES;

EID: 84947866189     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2015.06.003     Document Type: Article

References (45)

1. R. Adam, E. Hoti, G. Folprecht, and A.B. Benson Accomplishments in 2008 in the management of curable metastatic colorectal cancer Gastrointest Cancer Res 3 2009 S15 S22
2. N.N. Hanna Radiofrequency ablation of primary and metastatic hepatic malignancies Clin Colorectal Cancer 4 2004 92 100
3. S.R. Alberts, and G.J. Poston Treatment advances in liver-limited metastatic colorectal cancer Clin Colorectal Cancer 10 2011 258 265
4. R. Adam, and E. Vinet Regional treatment of metastasis: surgery of colorectal liver metastases Ann Oncol 15 2004 103 106
5. J.S. Tomlinson, W.R. Jarnagin, R.P. DeMatteo, and et al. Actual 10-year survival after resection of colorectal liver metastases defines cure J Clin Oncol 25 2007 4575 4580
6. N. Kemeny, Y. Huang, A.M. Cohen, and et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer N Engl J Med 341 1999 2039 2048
7. R.C. Martin, J. Joshi, K. Robbins, and et al. Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study Ann Surg Oncol 18 2011 192 198
8. L. Solbiati, T. Livraghi, S.N. Goldberg, and et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients Radiology 221 2001 159 166
9. K.T. Sato, R.J. Lewandowski, M.F. Mulcahy, and et al. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres-safety, efficacy, and survival Radiology 247 2008 507 515
10. A. Kennedy, S. Nag, R. Salem, and et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium Int J Radiat Oncol Biol Phys 68 2007 13 23
11. A.M. Campbell, I.H. Bailey, and M.A. Burton Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy Phys Med Biol 45 2000 1023 1033
12. R.A. Sharma, G.A. Van Hazel, B. Morgan, and et al. Radioembolization of liver metastases from colorectal cancer using yttrium-90 microspheres with concomitant systemic oxaliplatin, fluorouracil, and leucovorin chemotherapy J Clin Oncol 25 2007 1099 1106
13. T.F. Jakobs, R.T. Hoffmann, K. Dehm, and et al. Hepatic yttrium-90 radioembolization of chemotherapy-refractory colorectal cancer liver metastases J Vasc Interv Radiol 19 2008 1187 1195
14. M.A. Vente, M. Wondergem, I. van der Tweel, and et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis Eur Radiol 19 2009 951 959
15. M. Cosimelli, R. Golfieri, P.P. Cagol, and et al. Multi-centre phase II clinical trial of yttrium-90 resin microspheres alone in unresectable, chemotherapy refractory colorectal liver metastases Br J Cancer 103 2010 324 331
16. A. Hendlisz, M. Van den Eynde, M. Peeters, and et al. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy J Clin Oncol 28 2010 3687 3694
17. L. Bester, B. Meteling, N. Pocock, and et al. Radioembolization versus standard care of hepatic metastases: comparative retrospective cohort study of survival outcomes and adverse events in salvage patients J Vasc Interv Radiol 23 2012 96 105
18. C.T. Sofocleous, A.R. Garcia, N. Pandit-Taskar, and et al. Phase I trial of selective internal radiation therapy for chemorefractory colorectal cancer liver metastases progressing after hepatic arterial pump and systemic chemotherapy Clin Colorectal Cancer 13 2014 27 36
19. R. Cianni, C. Urigo, E. Notarianni, and et al. Selective internal radiation therapy with SIR-spheres for the treatment of unresectable colorectal hepatic metastases Cardiovasc Intervent Radiol 32 2009 1179 1186
20. M.F. Mulcahy, R.J. Lewandowski, S.M. Ibrahim, and et al. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres Cancer 115 2009 1849 1858
21. R.J. Lewandowski, K.G. Thurston, J.E. Goin, and et al. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging J Vasc Interv Radiol 16 2005 1641 1651
22. K. Memon, R.J. Lewandowski, L. Kulik, A. Riaz, M.F. Mulcahy, and R. Salem Radioembolization for primary and metastatic liver cancer Semin Radiat Oncol 21 2011 294 302
23. R.J. Lewandowski, K. Memon, M.F. Mulcahy, and et al. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy Eur J Nucl Med Mol Imaging 41 2014 1861 1869
24. A.S. Kennedy, C. Nutting, D. Coldwell, J. Gaiser, and C. Drachenberg Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers Int J Radiat Oncol Biol Phys 60 2004 1552 1563
25. G. Van Hazel, A. Blackwell, J. Anderson, and et al. Randomised phase 2 trial of SIR-Spheres (R) plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer J Surg Oncol 88 2004 78 85
26. B. Gray, G. Van Hazel, M. Hope, and et al. Randomised trial of SIR-Spheres((R)) plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer Ann Oncol 12 2001 1711 1720
27. B. Sangro, B. Gil-Alzugaray, J. Rodriguez, and et al. Liver disease induced by radioembolization of liver tumors: description and possible risk factors Cancer 112 2008 1538 1546
28. P. Therasse, S.G. Arbuck, E.A. Eisenhauer, and et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205 216
29. R.L. Wahl, H. Jacene, Y. Kasamon, and M.A. Lodge From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors J Nucl Med 50 suppl 1 2009 122S 150S
30. A.R. Haug, B.P. Tiega Donfack, C. Trumm, and et al. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer J Nucl Med 53 2012 371 377
31. I. Zerizer, A. Al-Nahhas, D. Towey, and et al. The role of early (1)(8)F-FDG PET/CT in prediction of progression-free survival after (9)(0)Y radioembolization: comparison with RECIST and tumour density criteria Eur J Nucl Med Mol Imaging 39 2012 1391 1399
32. M.J. Goldstein, and E.P. Mitchell Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer Cancer Invest 23 2005 338 351
33. R. Seidensticker, T. Denecke, P. Kraus, and et al. Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases Cardiovasc Intervent Radiol 35 2012 1066 1073
34. G.A. van Hazel, N. Pavlakis, D. Goldstein, and et al. Treatment of fluorouracil-refractory patients with liver metastases from colorectal cancer by using yttrium-90 resin microspheres plus concomitant systemic irinotecan chemotherapy J Clin Oncol 27 2009 4089 4095
35. D. Zorzi, A. Laurent, T.M. Pawlik, G.Y. Lauwers, J.N. Vauthey, and E.K. Abdalla Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases Br J Surg 94 2007 274 286
36. C.T. Sofocleous, E.N. Petre, M. Gonen, and et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy J Vasc Interv Radiol 22 2011 755 761
37. X. Wang, C.T. Sofocleous, J.P. Erinjeri, and et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases Cardiovasc Intervent Radiol 36 2013 166 175
38. R.T. Hoffmann, T.F. Jakobs, C.H. Kubisch, and et al. Radiofrequency ablation after selective internal radiation therapy with Yttrium90 microspheres in metastatic liver disease-Is it feasible? Eur J Radiol 74 2010 199 205
39. C.C. Compton, L.P. Fielding, L.J. Burgart, and et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999 Arch Pathol Lab Med 124 2000 979 994
40. B. Janne d'Othee, C.T. Sofocleous, N. Hanna, and et al. Development of a research agenda for the management of metastatic colorectal cancer: proceedings from a multidisciplinary research consensus panel J Vasc Interv Radiol 23 2012 153 163
41. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Semin Liver Dis 30 2010 52 60
42. R. Murthy, R. Nunez, J. Szklaruk, and et al. Yttrium-90 microsphere therapy for hepatic malignancy: devices, indications, technical considerations, and potential complications Radiographics 25 suppl 1 2005 S41 S55
43. B. Atassi, A.K. Bangash, A. Bahram, and et al. Multimodality imaging following Y-90 radioembolization: a comprehensive review and pictorial essay Radiographics 28 2008 81 99
44. T. Szyszko, A. Al-Nahhas, R. Canelo, and et al. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography Nucl Med Commun 28 2007 15 20
45. C.Y. Wong, R. Salem, S. Raman, V.L. Gates, and H.J. Dworkin Evaluating 90Y-glass microsphere treatment response of unresectable colorectal liver metastases by [18F]FDG PET: a comparison with CT or MRI Eur J Nucl Med Mol Imaging 29 2002 815 820